Bio-Technical Resources

What Bio-Technical Resources does

Bio-Technical Resources (BTR) is a privately held U.S. contract research and development services provider focused on microbial biotechnology, operating as a division of Arkion Life Sciences, LLC since 2001. Founded in 1962 in Manitowoc, Wisconsin, BTR delivers integrated strain development, protein expression, fermentation process development, downstream processing, and analytical/biochemistry services to clients across biotechnology, fermentation, pharmaceutical, food, nutraceutical, agriculture, animal feed, biofuel, and industrial chemical end-markets.

The company runs its operations from a single 15,000 square-foot facility in Manitowoc, of which approximately 10,000 square feet is dedicated laboratory space. Technical capabilities include five non-proprietary microbial expression platforms (E. coli, Bacillus subtilis, Saccharomyces cerevisiae, Pichia pastoris, Trichoderma reesei), fermentation scale-up equipment ranging from 1-L to 250-L, downstream processing equipment spanning centrifugation, ultrafiltration, chromatography, homogenization, spray drying, and lyophilization, and a full analytical chemistry suite. Strain development combines classical mutagenesis with advanced recombinant methodologies including CRISPR-Cas genome editing, directed evolution, adaptive evolution, and metabolic engineering, supported by a multidisciplinary scientific staff of microbiologists, molecular biologists, biochemists, fermentation scientists, and biochemical engineers.

BTR generates revenue through professional-services contract R&D engagements sold directly to enterprise clients via a sales-led, quote-based motion. Programs range from feasibility studies to multi-year development efforts, all governed by NDAs, with all intellectual property developed during a program assigned to the client. The company does not operate e-commerce, reseller, or self-service channels, relying on direct technical engagement, technical content on its website, and selective industry event participation (including the SIMB Annual Meeting in 2026) for lead generation. No customer logos, revenue figures, or financial disclosures are publicly available.

Name

Bio-Technical Resources

Legal name

Bio-Technical Resources, a Division of Arkion Life Sciences, LLC

Website

https://biotechresources.com

Company type

Private

Founded year

1962

Operating status

Operating

Headcount range

11–50 employees

Short description

Bio-Technical Resources is a privately held U.S. contract R&D services provider that develops microbial strains, fermentation processes, and downstream processing for clients in biotechnology, pharmaceutical, food, nutraceutical, biofuel, agriculture, animal feed, and industrial chemical end-markets, operating from a single Manitowoc, Wisconsin facility as a division of Arkion Life Sciences, LLC.

Ownership category

akta.pro rank

Product category

Contract Microbial Biotechnology R&D Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF)

akta.pro secondary industries

Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

• Microbial strain development
• Fermentation process development
• Protein expression services
• Bioprocess scale-up
• Downstream processing services

Headquarters

HQ city

Manitowoc

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Contract R&D Services: Fee-for-service R&D contracts providing strain development, protein expression, fermentation process development, and downstream processing services. Intellectual property developed during service programs entirely belongs to the client. Programs are tailored to client goals and may range from months to years in duration.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Bio-Technical Resources is a contract R&D services company that develops microbial strains, fermentation processes, and downstream recovery methods for industrial clients. Service offerings span strain engineering (classical mutagenesis, CRISPR-Cas, directed/adaptive evolution), recombinant protein expression across five microbial hosts (E. coli, Bacillus subtilis, Saccharomyces cerevisiae, Pichia pastoris, Trichoderma reesei), fermentation process development and scale-up from 1-L to 250-L, downstream processing/recovery, and analytical/biochemistry support. All intellectual property developed during a service program belongs entirely to the client.

Product overview

Bio-Technical Resources is a contract R&D services company offering an integrated suite of biotechnology development services. The portfolio comprises six interconnected service lines: Strain Development Services (classical mutagenesis and recombinant strain engineering), Protein Expression Services (five microbial expression platforms), Fermentation Development Services (process optimization and scale-up), Integrated Strain & Process Development Services (combined approach), Downstream Processing Services (recovery and purification), and Analytical & Biochemistry Services (method development and validation). These services work together to deliver strains and robust commercial fermentation processes for clients across biotechnology, pharmaceutical, food, nutraceutical, chemical, biofuel, and agricultural industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Strain Development Services
• Protein Expression Services
• Fermentation Development Services Process development, optimization, and scale-up services using fermentors at 1-L, 14-L, 60-L, and 250-L scales, including demonstration and small-scale production runs suitable for technology transfer.
• Integrated Strain & Process Development Services Combined strain improvement and fermentation development approach that integrates dynamic, data-based design and testing of strains and processes for the fastest path to commercial production.
• Downstream Processing Services Recovery and purification of fermentation biomass and products, including protein recovery and purification at milligram-to-gram scales, using chromatography, ultrafiltration, and spray drying.
• Analytical & Biochemistry Services Internal analytical and biochemistry support for strain improvement and fermentation development programs, including method development and validation with experience satisfying FDA requirements.

Quantifiable outcome

• Over 20-fold production increase in optimized Bacillus strains for peptide and protein expression
• +2 more outcomes

Segments9 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Codexis: Codexis engineers enzymes and microbial strains for pharmaceutical and industrial biocatalysis applications, using directed evolution and process development capabilities that directly parallel BTR's strain engineering and fermentation services.
• Conagen: Conagen is a synthetic biology and strain engineering firm that develops microbial fermentation processes for ingredients, biopharmaceuticals, and specialty chemicals, closely matching BTR's strain development, protein expression, and scale-up services.
• Culture Biosciences: Culture Biosciences is a fermentation CRO offering bioreactor services and process development for biotech and industrial biology clients, directly comparable to BTR's fermentation development and scale-up offering.
• Bota Bio: Bota Bio provides strain engineering and fermentation process development for sustainable biomanufacturing of ingredients and materials, operating as a direct competitor in microbial R&D services to BTR.

Broad incumbents

• DSM-Firmenich: DSM-Firmenich operates large-scale biomanufacturing and strain development for food, nutrition, and health products, giving a broad incumbent benchmark for industrial biotech services comparable to BTR's contract R&D work.
• Ginkgo Bioworks: Ginkgo Bioworks operates a synthetic biology platform for cell engineering and fermentation process development across far broader applications and a much larger scale than BTR, representing a well-capitalized broad incumbent in microbial R&D services.
• Ajinomoto Bio-Pharma: Ajinomoto Bio-Pharma offers contract manufacturing and process development for biologics via microbial fermentation (e.g., Corynebacterium, E. coli), providing a broader scale, CDMO-side benchmark to BTR's development services.
• Novozymes (Novonesis): Novonesis (formerly Novozymes) is a global industrial enzyme and microbial technology company with strain and fermentation development capabilities that overlap with BTR's industrial and food biotechnology contracts.

Emerging players

• Zymergen (acquired by Ginkgo): Zymergen, now operating within Ginkgo Bioworks, automated strain engineering and bioprocess development for industrial biotech customers, representing an automation-forward emerging player adjacent to BTR's classical-plus-recombinant approach.
• Inscripta (now Avalo): Inscripta/Avalo has historically focused on genome editing tools and engineered microbial strain platforms, providing an emerging-player comparison point for BTR's CRISPR-enabled strain improvement services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bio-technical-resources-inc.
• Xx.com/btr_diagnostics
• Facebookfacebook.com/brgstaffing

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio-Technical Resources